The breast cancer pro-metastatic phenotype requires concomitant hyper-activation of ECM remodeling and dsRNA-IFN1 signaling in rare clone cells
N. Roda, A. Cossa, R. Hillje, A. Tirelli, F. Ruscitto, S. Cheloni, C. Priami, A. Dalmasso, V. Gambino, G. Blandano, A. Polazzi, P. Falvo, E. Gatti, L. Mazzarella, L. Luzi, , P. G. Pelicci
This study identifies that the breast cancer pro-metastatic phenotype arises from rare clones with hyper-activation of ECM remodeling and dsRNA-IFN1 signaling, and shows these genes predict metastasis progression.
bioRxiv · Jul 13, 2022Cancer Biology